Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
JAMA Netw Open. 2022 Feb 1;5(2):e2146331. doi: 10.1001/jamanetworkopen.2021.46331.
The application of precision medicine principles for the treatment of depressive disorders in adolescents requires an examination of the variables associated with depression outcomes in randomized clinical trials (RCTs).
To describe predictors, moderators, and mediators associated with outcomes in RCTs for the treatment of depressive disorders in adolescents.
A scoping review of RCTs for the treatment of depression in adolescents was conducted. Databases searched included MEDLINE, Embase, APA PsycInfo, and CINAHL. Included publications tested predictors, moderators, and/or mediators associated with depression symptom outcomes (eg, symptom reduction, response, remission) in RCTs pertaining to the treatment of adolescents, ages 13 to 17 years. Predictors were defined as variables that were associated with depression outcomes, independent of treatment group. Moderators were defined as baseline variables that were associated with differential outcomes between treatment groups. Mediators were defined by a formal mediation analysis. In duplicate, variables were extracted and coded with respect to analysis type (univariable or multivariable), statistical significance, direction of effect size, reporting of a priori hypotheses, and adjustment for multiple comparisons. Aggregated results were summarized by variable domain and RCT sample.
Eighty-one articles reporting on variables associated with outcomes across 33 RCTs were identified, including studies of biological (10 RCTs), psychosocial (18 RCTs), and combined (4 RCTs) treatments as well as a service delivery model (1 RCT). Fifty-three variable domains were tested as baseline predictors of depression outcome, 41 as moderators, 19 as postbaseline predictors, and 5 as mediators. Variable domains that were reported as significant in at least 3 RCTs included age, sex/gender, baseline depression severity, early response to treatment, sleep changes, parent-child conflict, overall psychopathology, suicidal ideation, hopelessness, functional impairment, attendance at therapy sessions, and history of trauma. Two publications reported a priori hypotheses and adjustment for multiple comparisons, both finding that baseline depression severity and family conflict were associated with poorer outcomes.
This review identified commonly researched variables requiring more scrutiny as well as underresearched variables to inform future study designs. Further efforts to discover predictors, moderators, and mediators associated with treatment response have great potential to optimize care for adolescents with depression.
将精准医学原则应用于青少年抑郁障碍的治疗需要检查随机临床试验 (RCT) 中与抑郁结局相关的变量。
描述与青少年抑郁障碍治疗 RCT 结局相关的预测因素、调节剂和中介因素。
对青少年抑郁症治疗的 RCT 进行了范围综述。检索的数据库包括 MEDLINE、Embase、APA PsycInfo 和 CINAHL。纳入的出版物测试了与青少年(13 至 17 岁)治疗相关的 RCT 中与抑郁症状结局(例如症状减轻、反应、缓解)相关的预测因素、调节剂和/或中介因素。预测因素定义为与治疗组无关的与抑郁结局相关的变量。调节剂定义为与治疗组之间不同结局相关的基线变量。中介物通过正式的中介分析来定义。对变量进行了重复提取和编码,内容涉及分析类型(单变量或多变量)、统计学意义、效应大小的方向、先验假设的报告以及对多次比较的调整。汇总结果按变量域和 RCT 样本进行总结。
确定了 81 篇报告与 33 项 RCT 中结局相关的变量的文章,包括生物治疗(10 项 RCT)、心理社会治疗(18 项 RCT)和联合治疗(4 项 RCT)以及一项服务提供模式(1 项 RCT)。对 53 个变量域进行了测试,作为抑郁结局的基线预测因素,41 个作为调节剂,19 个作为基线后预测因素,5 个作为中介因素。在至少 3 项 RCT 中报告为显著的变量域包括年龄、性别/性别、基线抑郁严重程度、早期治疗反应、睡眠变化、父母-子女冲突、总体精神病理学、自杀意念、绝望、功能障碍、参加治疗会议和创伤史。有两项出版物报告了先验假设并进行了多次比较的调整,都发现基线抑郁严重程度和家庭冲突与较差的结局相关。
本综述确定了需要更仔细研究的常见研究变量以及研究不足的变量,以提供未来研究设计的信息。进一步努力发现与治疗反应相关的预测因素、调节剂和中介因素,有可能优化青少年抑郁症患者的护理。